PixCell Medical raised $2 Million Following CE approval its CBC Analyzer
7 October, 2013
“PixCell’s goal is to make lab restricted tests more accessible, easy to use and affordable”
The cells flowing through a microchannel are focused into a single plane, which enables their optical detection and analysis
PixCell Medical Technologies Ltd. from Yokneam, Israel, announced that it has raised $2 million from its existing strategic investor, following successful completion of CE mark registration of the HemoScreen Complete Blood Count (CBC) analyzer.
This investment will be used to establish PixCell’s European presence and expand its ongoing clinical efforts. HemoScreen CBC analyzer requires only a minute blood sample and zero maintenance, it is also ideal for newborns hematology assessment.
PixCell’s analyzers use a unique patented technology that is based on a recently discovered physical phenomenon called Viscoelastic Focusing. This fenomena was first discovered at the Technion – Israel Institute of Technology. In Viscoelastic Focusing, in a fluid of specific rheological properties, lateral migration of particles results in their perfect alignment at the center of flow. Thus focusing is achieved requiring neither sheath flow nor complex geometries. The method is stable in fluctuations and independent of flow velocity, significantly reducing the complexity of the flow mechanism.
“PixCell’s goal is to make lab restricted tests more accessible, easy to use and affordable”, said PixCell Medical CEO Dr. Avishay Bransky. “With this new investment, PixCell is poised to expand its clinical efforts and further demonstrate how the HemoScreen technology can support diagnostics and treatment selection at the point of care.”
PixCell’s HemoScreen is a miniature, portable Point of Care Complete Blood Count (CBC) tester that employs disposable self-contained cartridges. The HemoScreen provides 20 standard CBC parameters including: RBC indices, WBC count, Hemoglobin, WBC 5-diff and platelets parameters. Tests results are obtained within 5 minutes using only 20µl of capillary/venous blood.
Posted in: Medical , News , Technology